Vivos Therapeutics, Inc. (VVOS)

Import this data to Google Sheets with:

=jivedata("VVOS","financials")

Full statements spill as a table. For one cell: =jivedata("VVOS","Revenue") or =jivedata("VVOS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Vivos Therapeutics, Inc.

VVOS • CIK 0001716166

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$5,530	$6,012	$6,901	$7,964
Gross Profit	$8,271	$9,019	$10,542	$12,938
Operating Income (Loss)	$-17,296	$-11,171	$-19,894	$-22,554
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-13,583	$-11,136	$-21,230	$-25,627
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$-21,230	$-25,627
Net Income (Loss) Attributable to Noncontrolling Interest	—	—	$-60	$-60
Net Income (Loss) Attributable to Parent	$-13,583	$-11,136	$-21,170	$-25,456
Weighted Average Number of Shares Outstanding, Basic	1,219,381	5,019,886	10,273,881	17,597,727
Revenue from Contract with Customer, Excluding Assessed Tax	$13,801	$15,031	$17,443	$20,902
General and Administrative Expense	$22,479	$17,878	$27,727	$32,512
Selling and Marketing Expense	$2,467	$1,731	$1,400	$1,189
Depreciation, Depletion and Amortization, Nonproduction	$621	$581	$1,309	$1,791
Operating Expenses	$25,567	$20,190	$30,436	$35,492
Other Nonoperating Income (Expense)	$-212	$-110	$-1,481	$-3,529
Other Income	$147	$145	$145	$456

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$1,643	$6,260	$2,029	$1,774
Accounts Receivable, after Allowance for Credit Loss, Current	$202	$430	$1,581	$1,438
Prepaid Expense and Other Assets, Current	$616	$783	$774	$1,001
Assets	$10,730	$15,284	$25,152	$24,144
Assets, Current	$2,461	$7,473	$4,384	$4,213
Stockholders' Equity Attributable to Noncontrolling Interest	—	—	$-60	$-171
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	—	—	$-1,550	$-3,986
Goodwill	$2,843	$2,843	$8,572	$8,572
Property, Plant and Equipment, Net	$3,314	$3,350	$3,757	$3,640
Operating Lease, Right-of-Use Asset	$1,385	$1,032	$4,166	$3,809
Intangible Assets, Net (Excluding Goodwill)	$420	$370	$4,045	$3,638
Deposits Assets, Noncurrent	$307	$216	$228	$272
Liabilities	$10,319	$7,330	$26,702	$28,130
Accounts Payable, Current	$2,145	$1,098	$1,679	$2,946
Accrued Liabilities, Current	$2,334	$2,234	$5,988	$7,042
Contract with Customer, Liability, Current	$2,138	$896	$479	$583
Operating Lease, Liability, Current	$474	$477	$672	$790
Finance Lease, Liability, Current	—	—	$55	$56
Long-term Debt, Current Maturities	—	—	$8,353	$7,772
Other Liabilities, Current	$198	$273	$850	$1,200
Liabilities, Current	$7,289	$4,978	$18,076	$20,389
Contract with Customer, Liability, Noncurrent	$289	$97	$97	$1
Operating Lease, Liability, Noncurrent	$1,521	$1,035	$3,840	$3,438
Finance Lease, Liability, Noncurrent	—	—	$113	$83
Long-term Debt, Excluding Current Maturities	—	—	$469	$366
Other Liabilities, Noncurrent	—	—	$1,300	$950
Common Stock, Value, Issued	—	—	$1	$1
Additional Paid in Capital	$93,462	$112,141	$123,866	$133,599
Retained Earnings (Accumulated Deficit)	$-93,051	$-104,187	$-125,357	$-138,520
Stockholders' Equity Attributable to Parent	$411	$7,954	$-1,490	$-3,815
Accounts Receivable, Allowance for Credit Loss	$250	$390	$882	$1,179
Preferred Stock, Shares Authorized	50,000,000	50,000,000	50,000,000	50,000,000
Preferred Stock, Shares Issued	0	0	0	3,608,495
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	1,833,877	5,889,520	9,286,609	14,531,617

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$-21,230	$-25,627
Net Cash Provided by (Used in) Operating Activities	$-11,946	$-12,691	$-15,263	$-17,131
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-1,876	$4,617	$-4,231	$-2,628
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$1,643	$6,260	$2,029	$1,797
Share-based Payment Arrangement, Noncash Expense	$1,106	$762	$661	$303
Payments to Acquire Property, Plant, and Equipment	$803	$568	$2,341	$1,882
Depreciation, Depletion and Amortization	$621	$581	$1,309	$1,309
Payments to Acquire Other Productive Assets	$50	$50	$5,185	$5,185
Issuance of Stock and Warrants for Services or Claims	$87	$11	$11	—
Net Cash Provided by (Used in) Investing Activities	$-853	$-568	$-7,526	$-1,932
Adjustment of Warrants Granted for Services	$737	$31	$31	$31
Proceeds from Issuance of Common Stock	—	$7,796	$5,576	$5,862
Proceeds from Issuance of Long-term Debt	—	—	$10,673	$4,056
Proceeds from Issuance of Warrants	—	—	$1,699	$1,562
Proceeds from Warrant Exercises	—	$7,500	$866	$3,359
Payments of Stock Issuance Costs	$1,077	$1,361	$837	$837
Finance Lease, Principal Payments	—	—	$28	$28
Net Cash Provided by (Used in) Financing Activities	$10,923	$17,876	$18,558	$16,435
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$9	$9	—
Increase (Decrease) in Accounts Receivable	$-255	$228	$217	$-195
IncreaseDecreaseInOperatingLeaseLiability	$-109	$-129	$55	$189
Increase (Decrease) in Prepaid Expense and Other Assets	$-832	$167	$-19	$306
Increase (Decrease) in Deposit Assets	$-80	$-105	$-29	$79
Increase (Decrease) in Accounts Payable	$734	$-1,048	$524	$1,184
Increase (Decrease) in Accrued Liabilities	$422	$-39	$3,618	$4,799
Increase (Decrease) in Other Operating Liabilities	$41	$41	$483	$-164
Increase (Decrease) in Contract with Customer, Liability	$-611	$-1,434	$-514	$98

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VVOS","financials")

Full statements spill as a table. For one cell: =jivedata("VVOS","Revenue") or =jivedata("VVOS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.